go back

Granisetron, Oral

Maryland rates for HCPCS Q0166

Granisetron HCl, 1 mg, oral, FDA-approved prescription antiemetic, for use as a complete therapeutic substitute for an IV antiemetic at the time of chemotherapy treatment, not to exceed a 24-hour dosage regimen

Rates data updated July 2026.

Facilitymedian $3 · 10th–90th $3$40%50%90th$3Professionalmedian $3 · 10th–90th $1$30%50%10th90th$3$1.0$2.0$5.0$10.0$20.0$50.0$100.0

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$3.09
Median
$3.09
Typical High
$3.80
Aetna
Setting
Professional
Modifier
Global
Typical Low
$2.88
Median
$3.02
Typical High
$3.09
CareFirst
Setting
Professional
Modifier
Global
Typical Low
$1.45
Median
$1.45
Typical High
$1.45
Cigna
Setting
Professional
Modifier
Global
Typical Low
$3.09
Median
$3.09
Typical High
$3.09
Kaiser Permanente
Setting
Professional
Modifier
Global
Typical Low
$26.92
Median
$47.86
Typical High
$61.66
United
Setting
Facility
Modifier
Global
Typical Low
$3.02
Median
$3.09
Typical High
$3.09
United
Setting
Professional
Modifier
Global
Typical Low
$3.02
Median
$3.02
Typical High
$50.12
Wellpoint
Setting
Professional
Modifier
Global
Typical Low
$1.45
Median
$1.45
Typical High
$1.45